Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Methylnitrosourea. Found 4 abstracts

Badawi AF, Eldeen MB, Liu Y, Ross EA, Badr MZ. Inhibition of rat mammary gland carcinogenesis by simultaneous targeting of cyclooxygenase-2 and peroxisome proliferator-activated receptor gamma. Cancer Research. 2004 Feb;64(3):1181-9.
Lu S, Zhang X, Badawi AF, El-Sohemy A, Archer MC. Cyclooxygenase-2 inhibitor celecoxib inhibits promotion of mammary tumorigenesis in rats fed a high fat diet rich in n-6 polyunsaturated fatty acids. Cancer letters. 2002 Oct 08;184(1):7-12.
Desaulniers D, Leingartner K, Russo J, Perkins G, Chittim BG, Archer MC, Wade M, Yang J. Modulatory effects of neonatal exposure to TCDD, or a mixture of PCBs, p,p'-DDT, and p-p'-DDE, on methylnitrosourea-induced mammary tumor development in the rat. Environ Health Perspect. 2001 Jul;109(7):739-47.
Russo J, Russo IH. Atlas and histologic classification of tumors of the rat mammary gland. J Mammary Gland Biol Neoplasia. 2000 Apr;5(2):187-200.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Methylnitrosourea

Rats Experimental Mammary Neoplasms Female Methylnitrosourea Animal chemically induced Sprague-Dawley Rats pathology Drug Dose-Response Relationship Non-US Gov't Support Cyclooxygenase Inhibitors Sulfonamides Anticarcinogenic Agents Isoenzymes Prostaglandin-Endoperoxide Synthase Prenatal Exposure Delayed Effects Apoptosis pd [Pharmacology] Transcription Factors administration & dosage Alkylating Agents 61-90-5 (Leucine) de [Drug Effects] Carcinogens pc [Prevention & Control] 35661-60-0 (N-(fluorenyl-9-methoxycarbonyl)leucine) Unsaturated Dietary Fats Polychlorinated Biphenyls 0 (Sulfonamides) 41598-07-6 (Prostaglandin D2) Cytoplasmic and Nuclear Receptors 0 (Fluorenes) ai [Antagonists & Inhibitors] control 10-Dimethyl-1 9-2-benzanthracene bi [Biosynthesis] Dinoprostone Cell Cycle 0 (15-deoxyprostaglandin J2) classification Intraductal Carcinoma-Noninfiltrating en [Enzymology] 0 (Anticarcinogenic Agents) Cytoplasmic and Nuclear) 0 (Receptors 0 (Carcinogens) prevention & ag [Agonists] Fluorenes Pregnancy Organochlorine Insecticides 169590-42-5 (celecoxib) drug effects 363-24-6 (Dinoprostone) Mammae 0 (Cyclooxygenase Inhibitors) Environmental Pollutants pharmacology Drug Synergism Prostaglandin D2 Unsaturated Fatty Acids Adenocarcinoma 0 (Isoenzymes) Cell Division DDT adverse effects ci [Chemically Induced] 0 (Transcription Factors) me [Metabolism] chemically ad [Administration & Dosage] 684-93-5 (Methylnitrosourea) Breast Dietary Fats pharmacokinetics toxicity aa [Analogs & Derivatives] induced EC 1-14-99-1 (cyclooxygenase 2) Leucine Tetrachlorodibenzodioxin DDE EC 1-14-99-1 (Prostaglandin-Endoperoxide Synthase) ph [Physiology] antagonists & inhibitors therapeutic use Neoplastic Cell Transformation
Last updated on Wednesday, February 05, 2020